Tag: ipo

BioVentus delays $150m IPO
Financial

BioVentus delays $150m IPO

JULY 29, 2016  BY FINK DENSFORD   Orthobiologics maker Bioventus postponed its initial public offering which was slated to raise up to $150 million for the company, according to Renaissance Capital. The company plans to float 8.8 million shares at a price range of between $16 and $18, and plans to list […]

Titan Medical Prices $6m Offering
Financial

Titan Medical Prices $6m Offering

BY BRAD PERRIELLO Titan Medical (CVE:TMD) today priced an 8.9-million-share offering at about 65¢ per share, saying it plans to use the proceeds to continue developing its Sport robot-assisted surgery platform. Toronto-based Titan said it could gross about $5.8 million (C$8 million) from the offering, which is slated to close Feb 12. […]

ConforMIS sets terms for $135m IPO
Financial

ConforMIS sets terms for $135m IPO

By Brad Perriello ConforMIS today set the terms for its forthcoming initial public offering, saying it plans to float 9 million shares at $14 to $16 apiece. At the midpoint of the range, the IPO would fetch $135 million. Bedford, Mass.-based ConforMIS said last month that the IPO could bring in as much […]

Vertos Medical raising $12M for lumbar spinal stenosis treatment. So when’s that IPO?
Financial Spine

Vertos Medical raising $12M for lumbar spinal stenosis treatment. So when’s that IPO?

By Meghana Keshavan Southern California devicemaker Vertos Medical has been around a decade, and has a clinically validated treatment for lumbar spinal stenosis. It’s raised many dollars in venture financing, and is in the midst of a new equity round. This begs the question – when will Vertos IPO? Vertos is aiming to raise $12 million, […]

Nevro boosts IPO to $126m
Financial Neuro

Nevro boosts IPO to $126m

MENLO PARK, Calif., Nov. 6, 2014 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced the pricing of its initial public offering of 7,000,000 shares of its common stock at a […]

Histogenics Files for IPO
Financial

Histogenics Files for IPO

Histogenics Corp. has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO). No terms were given for this offering but the filing is up to $65 million. The company will list on the Nasdaq Global Market under the symbol HSGX. The […]